Uk Astrazeneca Vaccine
- All
- News
- Videos
-
Covishield Side Effects: Doctors' Group Urges Centre To Review All Covid Vaccines
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine.
-
What Is TTS, A Rare Condition Caused By AstraZeneca's Covishield Vaccine
AstraZeneca, a British pharmaceutical giant, has admitted that its Covid-19 vaccine can result ina rare side effectknown as Thrombosis with Thrombocytopenia Syndrome (TTS).T
-
AstraZeneca Makes Big U-Turn, Admits Covishield Can Cause Rare Side Effects
British pharma giant AstraZeneca has admitted that its Covid vaccine can cause rare side effects, The Telegraph (UK) has reported.
-
Exclusive: Indian Students In UK Can Get Booster Shots At Walk-In Vaccination Centres
Indian students in the United Kingdom who have received two doses of AstraZeneca's Covishield vaccine will be able to get a booster shot, as per the new protocol announced by British Prime Minister Boris Johnson.
-
Mixing Covid Vaccines Is Effective In Study on Pfizer, AstraZeneca
Mixing other vaccines with those from AstraZeneca Plc or Pfizer Inc. offers at least as effective protection against Covid-19 as giving two doses of the same shots, a UK study found.
-
COVID-19 Has More Blood Clot Threat Than Vaccines, Says UK Study: Report
A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by the University of Oxford said on Friday.
-
Blood Clot Risk Much Higher From Covid Than With Vaccines: UK Study
Covid-19 patients face a much higher risk of developing blood clots than those vaccinated with AstraZeneca Plc or Pfizer Inc.'s shots, according to a large U.K. study.
-
Protection From Pfizer, AstraZeneca Jabs Wanes Within 6 Months: UK Study
Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers in Britain.
-
Covishield Shot Should Be Accepted In Travel Schemes: UK's Boris Johnson
British Prime Minister Boris Johnson on Friday said he saw no reason why people who received Indian-made AstraZeneca COVID-19 vaccines should be left out of vaccine passport schemes after the European Union did not initially recognise it.
-
Two Doses Mostly Prevent Hospitalisation With Delta Variant: UK Body
Two doses of COVID-19 vaccines are "highly effective" in preventing hospital admission with the Delta variant, Public Health England said on Monday.
-
Oxford, Pfizer Vaccines 80% Effective On Variant Found In India: Study
Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of COVID-19, first discovered in India, a new UK government study has reportedly found.
-
2 AstraZeneca Doses Give Up to 90% Protection From Covid Symptoms: UK
Two doses of AstraZeneca Plc's Covid-19 vaccine provide about 85% to 90% protection against symptomatic disease, according to statistics released by Public Health England on Thursday.
-
UK Advises Under-40s Get Alternative To AstraZeneca Covid Vaccine
The scientific committee overseeing Britain's coronavirus vaccination programme on Friday recommended that under-40s are offered an alternative to the Oxford-AstraZeneca Covid jab.
-
Adar Poonawalla To Invest Over $300 Million In UK
Vaccine maker the Serum Institute of India is set to invest in facilities in the United Kingdom and could even manufacture inoculations in the UKin future, British Prime Minister Boris Johnson said Monday.
-
One Dose Of Covid Vaccine Cuts Household Spread By Up To 50%: UK Study
One dose of the Pfizer or AstraZeneca vaccines reduces the chances of someone infected with coronavirus from spreading it to other household members by up to 50 percent, according to a English study published Wednesday.
-
Covishield Side Effects: Doctors' Group Urges Centre To Review All Covid Vaccines
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine.
-
What Is TTS, A Rare Condition Caused By AstraZeneca's Covishield Vaccine
AstraZeneca, a British pharmaceutical giant, has admitted that its Covid-19 vaccine can result ina rare side effectknown as Thrombosis with Thrombocytopenia Syndrome (TTS).T
-
AstraZeneca Makes Big U-Turn, Admits Covishield Can Cause Rare Side Effects
British pharma giant AstraZeneca has admitted that its Covid vaccine can cause rare side effects, The Telegraph (UK) has reported.
-
Exclusive: Indian Students In UK Can Get Booster Shots At Walk-In Vaccination Centres
Indian students in the United Kingdom who have received two doses of AstraZeneca's Covishield vaccine will be able to get a booster shot, as per the new protocol announced by British Prime Minister Boris Johnson.
-
Mixing Covid Vaccines Is Effective In Study on Pfizer, AstraZeneca
Mixing other vaccines with those from AstraZeneca Plc or Pfizer Inc. offers at least as effective protection against Covid-19 as giving two doses of the same shots, a UK study found.
-
COVID-19 Has More Blood Clot Threat Than Vaccines, Says UK Study: Report
A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by the University of Oxford said on Friday.
-
Blood Clot Risk Much Higher From Covid Than With Vaccines: UK Study
Covid-19 patients face a much higher risk of developing blood clots than those vaccinated with AstraZeneca Plc or Pfizer Inc.'s shots, according to a large U.K. study.
-
Protection From Pfizer, AstraZeneca Jabs Wanes Within 6 Months: UK Study
Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers in Britain.
-
Covishield Shot Should Be Accepted In Travel Schemes: UK's Boris Johnson
British Prime Minister Boris Johnson on Friday said he saw no reason why people who received Indian-made AstraZeneca COVID-19 vaccines should be left out of vaccine passport schemes after the European Union did not initially recognise it.
-
Two Doses Mostly Prevent Hospitalisation With Delta Variant: UK Body
Two doses of COVID-19 vaccines are "highly effective" in preventing hospital admission with the Delta variant, Public Health England said on Monday.
-
Oxford, Pfizer Vaccines 80% Effective On Variant Found In India: Study
Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of COVID-19, first discovered in India, a new UK government study has reportedly found.
-
2 AstraZeneca Doses Give Up to 90% Protection From Covid Symptoms: UK
Two doses of AstraZeneca Plc's Covid-19 vaccine provide about 85% to 90% protection against symptomatic disease, according to statistics released by Public Health England on Thursday.
-
UK Advises Under-40s Get Alternative To AstraZeneca Covid Vaccine
The scientific committee overseeing Britain's coronavirus vaccination programme on Friday recommended that under-40s are offered an alternative to the Oxford-AstraZeneca Covid jab.
-
Adar Poonawalla To Invest Over $300 Million In UK
Vaccine maker the Serum Institute of India is set to invest in facilities in the United Kingdom and could even manufacture inoculations in the UKin future, British Prime Minister Boris Johnson said Monday.
-
One Dose Of Covid Vaccine Cuts Household Spread By Up To 50%: UK Study
One dose of the Pfizer or AstraZeneca vaccines reduces the chances of someone infected with coronavirus from spreading it to other household members by up to 50 percent, according to a English study published Wednesday.
